Indications and Purposes
| 1 Indications And Usage Simbrinza (Brinzolamide And Brimonidine Tartrate Ophthalmic Suspension) 1% And 0.2% Is A Fixed Combination Of A Carbonic Anhydrase Inhibitor And An Alpha-2 Adrenergic Receptor Agonist Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension. Simbrinza Is A Fixed Combination Of A Carbonic Anhydrase Inhibitor And An Alpha-2 Adrenergic Receptor Agonist Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Brimonidine Tartrate |
|
ZINC895301 |
| 2. Brinzolamide |
|
ZINC3953037 |